NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 103 filers reported holding NURIX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,338,448 | -19.0% | 170,286 | +2.9% | 0.00% | – |
Q2 2023 | $1,653,046 | +17.6% | 165,470 | +4.5% | 0.00% | – |
Q1 2023 | $1,405,784 | -20.3% | 158,309 | -1.4% | 0.00% | – |
Q4 2022 | $1,762,774 | -14.8% | 160,544 | +1.1% | 0.00% | -100.0% |
Q3 2022 | $2,069,000 | +20.4% | 158,760 | +17.0% | 0.00% | – |
Q2 2022 | $1,719,000 | +17.9% | 135,703 | +30.3% | 0.00% | – |
Q1 2022 | $1,458,000 | -51.6% | 104,122 | +0.1% | 0.00% | -100.0% |
Q4 2021 | $3,011,000 | +2.2% | 104,018 | +5.8% | 0.00% | 0.0% |
Q3 2021 | $2,945,000 | +42.3% | 98,287 | +26.0% | 0.00% | – |
Q2 2021 | $2,070,000 | -0.2% | 78,027 | +17.0% | 0.00% | – |
Q1 2021 | $2,074,000 | +42.2% | 66,698 | +50.3% | 0.00% | – |
Q4 2020 | $1,459,000 | +49.8% | 44,374 | +59.1% | 0.00% | – |
Q3 2020 | $974,000 | – | 27,892 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14,327,860 | 1.60% |
DAFNA Capital Management LLC | 556,695 | $4,375,623 | 1.36% |
Redmile Group, LLC | 2,848,827 | $22,391,780 | 1.06% |
Deep Track Capital, LP | 2,997,830 | $23,562,944 | 0.91% |
WestHill Financial Advisors, Inc. | 283,333 | $2,226,997 | 0.65% |
Soleus Capital Management, L.P. | 814,000 | $6,398,040 | 0.59% |
Affinity Asset Advisors, LLC | 250,000 | $1,965,000 | 0.55% |
Boxer Capital, LLC | 1,224,892 | $9,627,651 | 0.51% |
AtonRa Partners | 24,227 | $190,424 | 0.40% |
WASATCH ADVISORS LP | 3,564,616 | $28,017,882 | 0.18% |